# Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis

> **NCT01941537** · PHASE2 · COMPLETED · sponsor: **Rockefeller University** · enrollment: 60 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** ILV-094
- **DRUG:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01941537
- **Lead sponsor:** Rockefeller University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-02
- **Final completion:** 2019-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01941537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01941537, "Randomized Placebo Controlled Study to Determine Safety, Pharmacodynamics and Efficacy of ILV-094 in Atopic Dermatitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01941537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*